TLR-4 Antagonist for NASH Flops in Phase IIa Trial (CME/CE)

(MedPage Today) -- Placebo actually outperformed JKB-121 in multiple endpoints
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Primary Care